Trials
1 active
1 in total
What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “Drug: Benznidazole Tablets 100 mg (functionally scored) or Tablets 12.5 mg”In the company’s words, NCT04024163 on ClinicalTrials.gov
- Tested for
- Chagas Disease
- Main trialPhase 3
- “This study evaluate the efficacy and safety of benznidazole in the treatment of chronic indeterminate Chagas disease in children. All subjects will receive benznidazole and results will be compared to historically to a placebo arm.”In the company’s words, NCT04024163 on ClinicalTrials.gov
Other drugs for Chagas Disease
- BenznidazoleLaboratorio Elea Phoenix S.A. · Phase 3
- LXE408Novartis · Phase 2
Coming up1
- 30 Aug 2027Phase 3 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials1
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 3Active, not recruiting | 30 Aug 2027 | Prospective Study of Benznidazole for Chagas' Disease Children With Chronic Indeterminate Chagas Disease |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 20 Nov 2026 · EU trials register (CTIS) updated 20 Nov 2026 · openFDA updated 20 Nov 2026